Skip to main content
SpringerLink
Log in

Long-QT-Syndrom

  • Leserbriefe
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Akorn Pharmaceuticals: Dear Health Care Professional letter. http://www.fda.gov/medwatch/safety/2001/inapsine. htm. Cited 8 Jul 2006

  2. Bailey P, Norton R, Karan S (2002) The FDA droperidol warning: is it justified? Anesthesiology 97: 288–289

    Article  Google Scholar 

  3. Charbit B, Albaladejo P, Funck-Bretano C et al. (2005) Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 102: 1094–1100

    Article  PubMed  Google Scholar 

  4. Drolet B, Zhang S, Deschenes D et al. (1999) Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 10: 1597–1604

    PubMed  Google Scholar 

  5. Gan TJ, White PF, Scuderi PE et al. (2002) FDA „black box“ warning regarding use of droperidol for postoperative nausea and vomiting: is it justified? Anesthesiology 97: 287

    Article  PubMed  Google Scholar 

  6. Habib AS, Gan TJ (2003) Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 96: 1377–1379

    Article  PubMed  Google Scholar 

  7. Kuryshev YA, Brown AM, Wang L et al. (2000) Interactions of the 5hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther 295: 614–620

    PubMed  Google Scholar 

  8. Lischke V, Behne M, Doelken P et al. (1994) Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 79: 983–986

    PubMed  Google Scholar 

  9. Rasche S, Koch T, Hübler M (2006) Das Long-QT-Syndrom in der Anästhesie. Anaesthesist 55: 229–246

    Article  PubMed  Google Scholar 

  10. Roden DM (2004) Drug-induced prolongation of the QT interval. New Engl J Med 350: 1013–1022

    Article  PubMed  Google Scholar 

  11. Scuderi PE (2003) Droperidol: many questions, few anwers. Anesthesiology 98: 289–290

    Article  PubMed  Google Scholar 

  12. Titier K, Girodet PO, Verdoux H et al. (2005) Atypical antipsychotics. From potassium channels to torsade de pointes and sudden death. Drug Saf 28: 35–51

    Article  PubMed  Google Scholar 

  13. US Food and Drug Administration: FDA STRENGTHENS WARNINGS FOR DROPERIDOL. TO 1–62. http://www.fda.gov/bbs/topics/ANSWERS/2001/ANS01123.html. Cited 8 Jul 2006

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf eine Verbindung mit folgender Firma/Firmen hin: Dr. Martin Tramèr hat im Auftrag von SINTETICA den klinischen Teil des Droperidol-Expertenberichtes verfasst. Drs. Stefan Zbinden und Martin Tramèr haben gemeinsam und im Auftrag von SINTETICA einen Gegenbericht zum initialen, negativen Bescheid von SWISSMEDIC zur Zulassung von Droperidol verfasst. Am SWISSMEDIC-Hearing vertraten sie die Interessen von SINTETICA.

Author information

Authors and Affiliations

  1. Klinik für Anästhesie und Intensivbehandlung, Kantonales Spital Sursee-Wolhusen, 6110, Wolhusen, Schweiz

    S. Zbinden

Authors
  1. S. Zbinden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to S. Zbinden, S. Zbinden or S. Rasche.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zbinden, S. Long-QT-Syndrom. Anaesthesist 55, 1006–1008 (2006). https://doi.org/10.1007/s00101-006-1067-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-006-1067-7

Search

Navigation